Prothena Corp Public (PRTA) Deferred Taxes (2013 - 2025)
Prothena Corp Public (PRTA) recorded quarterly Deferred Taxes of $44.9 million in Q2 2025, up 2786.06% quarter-over-quarter from -$1.7 million in Q1 2025, and up 1699.39% on a YoY basis from $2.5 million in Q2 2024.
Prothena Corp Public (PRTA) Deferred Taxes (2013 - 2025) Analysis & Trends
Prothena Corp Public's Deferred Taxes history runs 13 years deep, the most recent figure standing at $44.9 million for Q2 2025.
- In Q2 2025, Deferred Taxes rose 1699.39% year-over-year to $44.9 million; the TTM figure through Mar 2026 stood at $44.9 million (up 645.3% YoY), while the FY2025 annual figure was $43.2 million, up 562.65% from the prior year.
- Deferred Taxes was $44.9 million for Q2 2025 at Prothena Corp Public, up from -$1.7 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $44.9 million in Q2 2025 to a low of -$4.5 million in Q2 2023.
- Historically, Deferred Taxes has averaged $646888.9 across 5 years, with a median of -$2.4 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Deferred Taxes slumped 4088.89% in 2022, then jumped 1699.39% in 2025.
- A 5-year view of Deferred Taxes shows it stood at -$568000.0 in 2021, then sank by 468.66% to -$3.2 million in 2022, then retreated by 23.13% to -$4.0 million in 2023, then jumped by 43.75% to -$2.2 million in 2024, then jumped by 2107.64% to $44.9 million in 2025.
- The last three Deferred Taxes figures came in at $44.9 million (Q2 2025), -$1.7 million (Q1 2025), and -$2.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 44.91 Mn |
| Mar 31, 2025 | -1.67 Mn |
| Dec 31, 2024 | -2.24 Mn |
| Sep 30, 2024 | -1.52 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -3.98 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | -4.51 Mn |
| Mar 31, 2023 | -3.23 Mn |
| Dec 31, 2022 | -3.23 Mn |
| Sep 30, 2022 | -3.02 Mn |
| Jun 30, 2022 | -2.37 Mn |
| Mar 31, 2022 | -2.52 Mn |
| Dec 31, 2021 | -568,000.00 |
| Sep 30, 2021 | -72,000.00 |
| Jun 30, 2021 | 591,000.00 |
| Mar 31, 2021 | 4.62 Mn |
| Dec 31, 2020 | -120,000.00 |
| Sep 30, 2020 | -507,000.00 |